What Happened?
Palo Alto, CA-based Cellular-Biomedicine-Group Appointed Bizuo Liu as Chief Executive Officer
About the Company
Cellular Biomedicine Group (OTCQB: CBMG) is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. We are the result of the acquisition, transfer, commercialization and advancement of thirty years of research and human treatment experience in cellular medicine. Our cellular research and development comes from collaboration among scientists and doctors from the US, England and China. CBMG has been actively developing technologies and products based on defensible intellectual property.
About the Person
Bizuo Liu is Chief Executive Officer at Cellular Biomedicine Group. Previously, Bizuo held various senior HR leadership roles in the industry.
Info Source
News
Short Profile